drugset / Trial / NCT00986401
Safety and Tolerability of Trospium Chloride and Metformin Hydrochloride in Healthy Subjects
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to investigate the safety and tolerability of trospium chloride (Sanctura XR™) and metformin hydrochloride (Glucophage) when co-administered.
Timeline
- Start
- 2009-10
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 500 mg | Oral |
| Subject | Trospium | Small molecule | 60 mg | Oral |
Indications
No indication recorded.